glp-1 receptor agonist alternatives to ozempic PDB-101: Molecule of the Month: Agonists Research shows GLP-1 drugs are

Purity of the Compound: This is an often-overlooked but absolutely critical factor

Thymoquinone: review of its potential in the treatment of neurological diseases

Keywords , MASH , GLP-1 receptor agonists , hepatic steatosis , metabolic dysfunction , tirzepatide , semaglutide , survodutide 0 2 INTRODUCTION Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease (NAFLD), has emerged as the predominant hepatic pathology worldwide, impacting roughly twenty-five percent of the adult population [1,2]

[DOI] [PubMed] 409.Ayumi NS, Sahudin S, Hussain Z, Hussain M, Samah NHA